Evaluating a new type of ureteral stent to reduce pain and improve comfort for kidney stone patients
Clinical evaluation of a compliant, degradable ureteral stent to reduce patient pain and improve tolerability
This study is testing a new type of ureteral stent called Uriprene® that is designed to be more comfortable and easier to manage for people dealing with kidney stones, and by joining, you'll help us see how well it works in reducing pain and improving your experience compared to regular stents.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Adva-Tec, INC NIH-funded |
| Lab location | 1 site (Anderson, United States) |
| Project ID | NIH-10241270 on NIH RePORTER |
What this research studies
This research focuses on the development and clinical evaluation of a new degradable ureteral stent called Uriprene®, designed to alleviate pain and discomfort associated with traditional stents used in kidney stone management. The stent is engineered to soften after implantation and degrade naturally, eliminating the need for a secondary removal procedure. By participating in this research, patients will help assess the stent's effectiveness in improving their overall experience during treatment for kidney stones. The study aims to gather feedback on pain levels and tolerability compared to conventional stents.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are experiencing kidney stones and require ureteral stenting.
Not a fit: Patients who do not have kidney stones or those who are not candidates for ureteral stenting may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a significant reduction in pain and discomfort for patients undergoing kidney stone treatment.
How similar studies have performed: While traditional ureteral stents have been widely used, this approach with a degradable stent is novel and has not been extensively tested in clinical settings.
Where this research is happening
Anderson, United States
- Adva-Tec, INC — Anderson, United States (Active)
Researchers
- Principal investigator: Cartledge, Jennifer — Adva-Tec, INC
- Study coordinator: Cartledge, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.